pepmg_

Study summary · research use only

Revolutionary decellularized Alstroemeria stem-based nerve conduit integrated with GelMA and controlled IGF-1 LR3 release for enhanced rat sciatic nerve regeneration

Study · animal · International journal of biological macromolecules · 2025 · DOI 10.1016/j.ijbiomac.2025.147888 · PMID 41015370

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

This study in rats tested a decellularized plant-based nerve conduit made from Alstroemeria stem material, integrated with GelMA and releasing Insulin-like Growth Factor Long Arginine 3 (IGF-1 LR3), for repair of a 1 cm sciatic nerve defect. Thirty rats were assigned to six experimental groups (n = 5), and regeneration was assessed by gait analysis, electrophysiology, histology, and immunohistochemistry, comparing the conduit to autologous grafts and commercial conduits. The IGF-1 LR3-releasing decellularized conduit was associated with improved axonal regeneration, with outcomes comparable to autologous nerve grafts, and without systemic toxicity observed. The authors describe this as demonstrating potential for plant-based biomaterials in peripheral nerve repair.

Abstract

Peripheral nerve injuries lead to significant functional deficits, with no treatment achieving complete recovery. Autologous nerve grafting remains the gold standard, but it is limited by donor site morbidity. Artificial nerve conduits have been developed but have not matched the outcomes of autologous grafts. This study introduces the first-ever decellularized plant-based nerve conduit, fabricated from Alstroemeria stem material, integrated with GelMA, and featuring controlled release of Insulin-like Growth Factor Long Arginine 3 (IGF-1 LR3) for enhanced axonal regeneration. Thirty rats were assigned to six experimental groups (n = 5) and underwent a 1 cm sciatic nerve defect. Regeneration was assessed via gait analysis, electrophysiology, histology, and immunohistochemistry, comparing the decellularized conduit to autologous grafts and commercial conduits. The IGF-1 LR3-controlled releasing decellularized conduit significantly improved axonal regeneration and showed comparable performance to autologous nerve grafts, without inducing systemic toxicity. This novel conduit demonstrates the potential of plant-based biomaterials for effective peripheral nerve repair.

Read the full study on PubMed ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.